All Stories

  1. Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States

    Article • Hospital Practice, August 2018, Taylor & Francis

    Michael Ganz

  2. Cost-effectiveness of combination daclatasvir-sofosbuvir for treatment of genotype 3 chronic hepatitis C infection in the United States

    Article • Journal of Medical Economics, April 2017, Taylor & Francis

    Michael Ganz

  3. Key data elements for use in cost-utility modeling of biological treatments for rheumatoid arthritis

    Article • Journal of Medical Economics, January 2015, Informa Healthcare

    Michael Ganz, Brian Bekker Hansen